JP2025506201A5 - - Google Patents

Info

Publication number
JP2025506201A5
JP2025506201A5 JP2024547842A JP2024547842A JP2025506201A5 JP 2025506201 A5 JP2025506201 A5 JP 2025506201A5 JP 2024547842 A JP2024547842 A JP 2024547842A JP 2024547842 A JP2024547842 A JP 2024547842A JP 2025506201 A5 JP2025506201 A5 JP 2025506201A5
Authority
JP
Japan
Prior art keywords
disorder
disease
disability
disorders
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012660 external-priority patent/WO2023158584A1/en
Publication of JP2025506201A publication Critical patent/JP2025506201A/ja
Publication of JP2025506201A5 publication Critical patent/JP2025506201A5/ja
Pending legal-status Critical Current

Links

JP2024547842A 2022-02-15 2023-02-09 新規なビシクロペンタン誘導体 Pending JP2025506201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263310219P 2022-02-15 2022-02-15
US63/310,219 2022-02-15
PCT/US2023/012660 WO2023158584A1 (en) 2022-02-15 2023-02-09 New bicyclopentane derivatives

Publications (2)

Publication Number Publication Date
JP2025506201A JP2025506201A (ja) 2025-03-07
JP2025506201A5 true JP2025506201A5 (enExample) 2026-02-24

Family

ID=85781948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547842A Pending JP2025506201A (ja) 2022-02-15 2023-02-09 新規なビシクロペンタン誘導体

Country Status (5)

Country Link
US (1) US20250002452A1 (enExample)
EP (1) EP4479377A1 (enExample)
JP (1) JP2025506201A (enExample)
CN (1) CN118829626A (enExample)
WO (1) WO2023158584A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025252599A1 (en) * 2024-06-04 2025-12-11 Angelini Pharma S.P.A. Activating compounds of potassium channels kv7.2/kv7.3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
HRP20240012T1 (hr) 2019-02-06 2024-03-29 Eli Lilly And Company Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)uree kao kcnq potencijatori
CN115461327A (zh) * 2020-04-29 2022-12-09 爱杜西亚药品有限公司 螺脲衍生物
AU2021295422A1 (en) * 2020-06-25 2023-02-23 Idorsia Pharmaceuticals Ltd Cyclobutyl-urea derivatives

Similar Documents

Publication Publication Date Title
JP2026035701A5 (enExample)
JP2024133474A5 (enExample)
JP2023523569A5 (enExample)
CN100528151C (zh) 莫达非尼药物剂型
AU2018357775B2 (en) New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)
CN108721265B (zh) 通过给予秋水仙碱衍生物治疗或预防心血管事件
TWI389689B (zh) 氟利本西林（ｆｌｉｂａｎｓｅｒｉｎ）於治療停經前性慾疾病之用途
JP2018513107A5 (enExample)
JP2014517050A5 (enExample)
JPH0667841B2 (ja) 恐慌障害の軽減剤
KR20130093015A (ko) 트라마돌 및 콕시브의 공결정의 약학적 조성물
JP2022550919A5 (enExample)
JP2019533660A5 (enExample)
MX2024010637A (es) Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas.
JP2021504384A5 (enExample)
JP2021502392A5 (enExample)
JP2015517523A5 (enExample)
EA202190544A1 (ru) Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний
JP2025506201A5 (enExample)
JP2024503727A5 (enExample)
JP2022169780A5 (enExample)
JP7123205B2 (ja) 経口用医薬組成物
JP2023531930A5 (enExample)
JP2022505184A5 (enExample)
JP2023528895A5 (enExample)